An ultrasound-guided core needle biopsy of the right breast lesion found high-grade infiltrating ductal carcinoma, estrogen receptor (ER) negative, progesterone receptor (PR) negative, and human epidermal growth factor receptor 2 (HER2) negative. The gene discussed is ESR1; the disease is invasive ductal breast carcinoma.